Skip to search formSkip to main contentSkip to account menu

pamaquine

Known as: 8-((4-(diethylamino)-1-methylbutyl)amino)-6-methoxyquinoline, N(1),N(1)-diethyl-N(4)- (6-methoxy-8-quinolinyl)-1,4-pentanediamine, plasmocide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1975
1975
The binding of pamaquine to bovine serum albumin is accompanied by the enhancement of the fluorescence efficiency of the former… 
1974
1974
The causal prophylactic activity of several reference and experimental antimalarial compounds was assessed in sporozoite-induced… 
1971
1971
Fluorocitrate, and fluoroacetate block the Krebs cycle in neural tissue, cause convulsive seizures, and produce interesting… 
1965
1965
In recent years a number of cases of quartan malaria have been noted following blood transfusion and haemotherapy. Clinical and… 
1964
1964
PLASMOCIDE ( 8[ 3-diethylaminopropylamino] 6-methoxy-quinoline) was originally synthesized as an antimalarial agent but, when… 
1960
1960
The discovery of antimalarial properties of derivatives of 8-aminoquinolines which combine high activity against the tissue… 
1951
1951
Summary A metabolite of pamaquine hitherto undescribed has been obtained from the tissues and droppings of treated chickens. The… 
1950
1950
Summary Two metabolites of pamaquine have been demonstrated in the plasma and urine of humans and dogs receiving pamaquine. One… 
1948
1948
The individuals used in these studies were, for the most part, patients with central nervous system syphilis. Certain of the…